Stay updated on CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no substantive changes to study details, eligibility criteria, or contact information observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:39:36.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T22:50:35.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:36.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding warning that information may not be up to date was removed from the page. Core study details, contacts, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:22.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The two screenshots depict the same study detail page with only minor visual and layout differences; no substantive updates to the study data (eligibility, enrollment, or outcomes) were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:30:34.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:47:58.000Z thumbnail image

Stay in the know with updates to CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTA and Methylation in NSCLC Response to Pembrolizumab Clinical Trial page.